JP2020189845A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020189845A5 JP2020189845A5 JP2020127888A JP2020127888A JP2020189845A5 JP 2020189845 A5 JP2020189845 A5 JP 2020189845A5 JP 2020127888 A JP2020127888 A JP 2020127888A JP 2020127888 A JP2020127888 A JP 2020127888A JP 2020189845 A5 JP2020189845 A5 JP 2020189845A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- fibrosis
- inhibitor
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022199857A JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015903035 | 2015-07-30 | ||
| AU2015903035A AU2015903035A0 (en) | 2015-07-30 | Fibrotic treatment | |
| JP2018504650A JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504650A Division JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199857A Division JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020189845A JP2020189845A (ja) | 2020-11-26 |
| JP2020189845A5 true JP2020189845A5 (https=) | 2021-04-01 |
| JP7457360B2 JP7457360B2 (ja) | 2024-03-28 |
Family
ID=57883919
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504650A Withdrawn JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
| JP2020127888A Active JP7457360B2 (ja) | 2015-07-30 | 2020-07-29 | 線維症の処置 |
| JP2022199857A Pending JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504650A Withdrawn JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199857A Pending JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US10100311B2 (https=) |
| EP (1) | EP3328384B1 (https=) |
| JP (3) | JP2018527330A (https=) |
| AU (1) | AU2016301113B2 (https=) |
| CA (1) | CA3017028C (https=) |
| HK (1) | HK1256423A1 (https=) |
| SG (1) | SG11201808478RA (https=) |
| WO (1) | WO2017015720A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016259977A1 (en) * | 2015-05-08 | 2017-11-23 | Monash University | 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors |
| CA3017028C (en) | 2015-07-30 | 2020-06-16 | Monash University | Fibrotic treatment |
| AU2018303333B2 (en) * | 2017-07-17 | 2023-02-09 | Monash University | Angiotensin receptor agonists and uses thereof |
| JP2022516611A (ja) * | 2018-12-28 | 2022-03-01 | ザ ジェネラル ホスピタル コーポレイション | 線維性疾患の治療のための抗エフリン－ｂ２遮断抗体 |
| WO2021050089A1 (en) * | 2019-09-09 | 2021-03-18 | Washington State University | Genetic test for identifying cats at a high risk for developing tubulointerstitial fibrosis |
| TW202143994A (zh) | 2020-02-19 | 2021-12-01 | 美商希皮恩製藥公司 | 環孢素類似物於治療纖維化之用途 |
| EP4440570A1 (en) * | 2021-12-01 | 2024-10-09 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Irap inhibitors for use in the treatment of inflammatory diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ553688A (en) * | 2004-09-09 | 2011-05-27 | Florey Howard Inst | Enzyme inhibitors for the inhibition of insulin-regulated aminopeptidase |
| CN101247819A (zh) * | 2005-08-23 | 2008-08-20 | 惠氏公司 | 治疗焦虑症和鉴定抗焦虑剂的方法 |
| WO2009065169A1 (en) * | 2007-11-19 | 2009-05-28 | Howard Florey Institute | Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof |
| KR20150028761A (ko) | 2011-12-16 | 2015-03-16 | 타릭스 파마슈티컬스 엘티디. | 섬유증 치료용 안지오텐신 |
| JP2015509483A (ja) * | 2012-02-06 | 2015-03-30 | グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー２、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｎｏ．２ Ｌｉｍｉｔｅｄ | 線維症を治療するためのｐｉ３ｋ阻害剤 |
| JP6327923B2 (ja) | 2014-04-25 | 2018-05-23 | 旭化成株式会社 | ポリアセタール樹脂組成物、及びそれからなる成形体 |
| DE102014114090A1 (de) | 2014-09-29 | 2016-03-31 | Karlsruher Institut für Technologie | Verfahren zur Abtrennung von Aluminium bei der Calciumsilikatproduktion |
| US9519061B2 (en) * | 2014-12-26 | 2016-12-13 | Here Global B.V. | Geometric fingerprinting for localization of a device |
| AU2016259977A1 (en) * | 2015-05-08 | 2017-11-23 | Monash University | 4H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors |
| CA3017028C (en) * | 2015-07-30 | 2020-06-16 | Monash University | Fibrotic treatment |
-
2016
- 2016-07-29 CA CA3017028A patent/CA3017028C/en active Active
- 2016-07-29 AU AU2016301113A patent/AU2016301113B2/en active Active
- 2016-07-29 WO PCT/AU2016/050681 patent/WO2017015720A1/en not_active Ceased
- 2016-07-29 EP EP16829507.9A patent/EP3328384B1/en active Active
- 2016-07-29 JP JP2018504650A patent/JP2018527330A/ja not_active Withdrawn
- 2016-07-29 SG SG11201808478RA patent/SG11201808478RA/en unknown
- 2016-07-29 US US15/747,697 patent/US10100311B2/en active Active
- 2016-07-29 HK HK18115556.4A patent/HK1256423A1/zh unknown
-
2018
- 2018-09-06 US US16/123,898 patent/US10787668B2/en active Active
-
2020
- 2020-07-29 JP JP2020127888A patent/JP7457360B2/ja active Active
- 2020-08-04 US US16/984,996 patent/US11078488B2/en active Active
-
2021
- 2021-07-01 US US17/365,260 patent/US11834663B2/en active Active
-
2022
- 2022-12-15 JP JP2022199857A patent/JP2023030022A/ja active Pending
-
2023
- 2023-10-26 US US18/495,512 patent/US20240084308A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020189845A5 (https=) | ||
| JP2018527330A5 (https=) | ||
| JP6526306B2 (ja) | バルドキソロンメチルまたはその類似体を使用して内皮機能障害を処置および予防する方法 | |
| ES2892954T3 (es) | Derivados fluorados del ácido 3-(2-oxo-3-(3-(5,6,7,8-tetrahidro-1,8-naftiridin-2-il)propil)imidazolidin-1-il)propanoico y usos de los mismos | |
| JP4692281B2 (ja) | 新規アゾール化合物 | |
| JP3187535B2 (ja) | 医薬的に活性なヒドラジン誘導体およびその製造方法 | |
| BR122018015003B1 (pt) | kit compreendendo composições farmacêuticas de inibidor da nep e de valsartan ou seus sais | |
| JP2023030022A5 (https=) | ||
| JP7457360B2 (ja) | 線維症の処置 | |
| JPWO2002092068A1 (ja) | カルボン酸誘導体化合物およびそれらを有効成分とする薬剤 | |
| JPH09506368A (ja) | 複素環式脱離基を含むシステインプロテアーゼインヒビター | |
| JPWO2007083689A1 (ja) | プラスミノーゲンアクチベーターインヒビター−１阻害剤 | |
| JPH08508720A (ja) | ピロールーアミジン化合物およびその薬剤的に受容できる塩、その製造法ならびにこれを含む医薬組成物 | |
| JP2021519312A (ja) | カルパインモジュレーター及びその治療的使用 | |
| JP5410278B2 (ja) | βセクレターゼ阻害活性を有する新規化合物 | |
| US20240350442A1 (en) | Methods of treating cancer | |
| JPH10130144A (ja) | アルツハイマー病の治療および予防用の医薬を製造するための非ペプチドのブラジキニンアンタゴニストの使用 | |
| US20190169185A1 (en) | Substituted 2-n-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same | |
| US20050130941A1 (en) | Methods of treating alzheimer's disease | |
| JP2007131532A (ja) | 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬 | |
| JP2023505598A (ja) | 化合物及びα１－アンチトリプシン欠損症の治療のためのそれらの使用 | |
| JP2002544119A (ja) | フェニルアラニン誘導体 | |
| TW201215389A (en) | Sustained-release therapeutic agent for hypertension and renal dysfunction | |
| JPH0529209B2 (https=) | ||
| US20210260153A1 (en) | Use of cyclosporine analogues for treating fibrosis |